Current Trials

F01323 – COVID-19 & Flu Vaccine Trial

 Fusion Clinical Research, Norwood

This study aims to assess the efficacy of a new COVID vaccine that is to be administered in conjunction with an approved Flu vaccine.

Study Population: Healthy participants or individuals with pre-existing stable medical conditions older than 18 years of age who have received the primary vaccination series and at least one booster dose of the authorized mRNA COVID-19 vaccines (Pfizer or Moderna), ≥5 months prior to enrolment.

Clinical Visits: Screening, Day 1, 29, 57, and 181

Main Inclusion Criteria:

  • Individuals are male, female, or transgender adults older than 18 years of age;
  • Healthy participants or participants with pre-existing stable medical conditions.
  • Individuals must agree to comply with all study visits and procedures.
  • Individuals who received at least 3 doses of the authorized (Pfizer or Moderna) mRNA COVID- 19 vaccines. The last booster dose must be an authorized (Pfizer or Moderna) mRNA COVID-19 vaccine, administered at least 5 months prior to enrolment.

Main Exclusion Criteria*:

  • Individuals with acute medical illness

  • Individuals who have had a COVID infection in the last 5 months, or have long COVID.

  • Individuals who received any influenza vaccine within 6 months prior to enrolment.

  • Individuals with a known history of severe hypersensitivity reactions, including anaphylaxis, or other significant adverse reactions to any mRNA vaccine, influenza vaccine, or excipients.

  • Individuals with a history of myocarditis, pericarditis, myopericarditis, or cardiomyopathy.

  • Cannot have any history of Guillain-Barre syndrome, encephalomyelitis or transverse myelitis.


*This list is not exhaustive


Untitled design (5)

Eligibility requirements

  • Age: 18-80
  • Sex: M, F, Transgender
  • Medical History: Need to be able to provide records of your COVID vaccination history.

Overnight Stays

  • Nil

Outpatient Visits

  • 5


  • $850 if all visits and activities are completed

How to apply

To register your interest in this trial, please complete this form, or call us on 1800-FUSION (1800 387 466). A Fusion team member will be in contact to discuss your eligibility shortly.